These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 15908677)
1. What you may learn from the Dutch experience. van den Brink M; van den Hout WB; Stiggelbout AM; Kievit J; van de Velde CJ J Clin Oncol; 2005 May; 23(15):3632-3; author reply 3633-4. PubMed ID: 15908677 [No Abstract] [Full Text] [Related]
2. Economics of preoperative radiotherapy with total mesorectal excision: what can we learn from the Dutch experience? Simunovic M; Gafni A; Levine M J Clin Oncol; 2004 Jan; 22(2):217-9. PubMed ID: 14665616 [No Abstract] [Full Text] [Related]
3. Rectal cancer adjuvant therapy controversies: When? What? Why? Rakinic J; Fry R Surg Oncol Clin N Am; 2000 Oct; 9(4):801-8; discussion 809-11. PubMed ID: 11008247 [TBL] [Abstract][Full Text] [Related]
4. Preoperative irradiation and surgery for local recurrence of rectal and rectosigmoid cancer. Prognostic factors with regard to survival and further local recurrence. Wiig JN; Larsen SG; Dueland S; Giercksky KE Colorectal Dis; 2008 Jan; 10(1):48-57. PubMed ID: 18028472 [TBL] [Abstract][Full Text] [Related]
5. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers. Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634 [TBL] [Abstract][Full Text] [Related]
6. Introduction of preoperative radiotherapy in the treatment of operable rectal cancer in the Southwest region of the Netherlands. Vermaas M; Gosselink MP; Ferenschild FT; van den Aardweg E; Lont HE; Kemperman HW; van der Harst E; Tetteroo GW; Oostenbroek RJ; Dijkhuis CM; Eggermont AM; de Wilt JH Eur J Surg Oncol; 2007 Sep; 33(7):862-7. PubMed ID: 17257804 [TBL] [Abstract][Full Text] [Related]
7. [Advantages of neoadjuvant therapy in rectal neoplasm]. Nano M; Ferronato M; Solej M; D'Amico S G Chir; 2008 May; 29(5):197-202. PubMed ID: 18507953 [No Abstract] [Full Text] [Related]
8. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy. Lindebjerg J; Spindler KL; Ploen J; Jakobsen A Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119 [TBL] [Abstract][Full Text] [Related]
9. Hydronephrosis as a prognostic factor in pelvic recurrence from rectal and colon carcinomas. Larsen SG; Wiig JN; Giercksky KE Am J Surg; 2005 Jul; 190(1):55-60. PubMed ID: 15972173 [TBL] [Abstract][Full Text] [Related]
10. Cost determinants in aggressive non-Hodgkin's lymphoma. van Agthoven M; Sonneveld P; Verdonck LF; Uyl-de Groot CA Haematologica; 2005 May; 90(5):661-71. PubMed ID: 15921381 [TBL] [Abstract][Full Text] [Related]
11. The correlation between tumour regression grade and lymph node status after chemoradiation in rectal cancer. Berho M; Oviedo M; Stone E; Chen C; Nogueras J; Weiss E; Sands D; Wexner S Colorectal Dis; 2009 Mar; 11(3):254-8. PubMed ID: 18513188 [TBL] [Abstract][Full Text] [Related]
12. Questionable benefit of short course radiotherapy for rectal cancer. Barreto SG; Shukla PJ Ann Surg; 2008 Jun; 247(6):1086; author reply 1086-7. PubMed ID: 18520254 [No Abstract] [Full Text] [Related]
13. Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancer. Supiot S; Bennouna J; Rio E; Meurette G; Bardet E; Buecher B; Dravet F; Le Neel JC; Douillard JY; Mahé MA; Lehur PA Colorectal Dis; 2006 Jun; 8(5):430-5. PubMed ID: 16684088 [TBL] [Abstract][Full Text] [Related]
14. Harm and benefits of short-term pre-operative radiotherapy in patients with resectable rectal carcinomas. Bakx R; Emous M; Legemate DA; Zoetmulder FA; van Tienhoven G; Bemelman WA; van Lanschot JJ Eur J Surg Oncol; 2006 Jun; 32(5):520-6. PubMed ID: 16600560 [TBL] [Abstract][Full Text] [Related]
15. Improved overall survival for patients with rectal cancer since 1990: the effects of TME surgery and pre-operative radiotherapy. den Dulk M; Krijnen P; Marijnen CA; Rutten HJ; van de Poll-Franse LV; Putter H; Meershoek-Klein Kranenbarg E; Jansen-Landheer ML; Coebergh JW; van de Velde CJ Eur J Cancer; 2008 Aug; 44(12):1710-6. PubMed ID: 18573654 [TBL] [Abstract][Full Text] [Related]
16. Transabdominal transanal resection of distal rectal cancer after high dose preoperative radiotherapy: a Chinese experience in preserving sphincter function. Zhou JN; Wang DZ; Huang XE; Xu FP; Shang JQ; Gu RM Isr Med Assoc J; 2006 Oct; 8(10):675-8. PubMed ID: 17125111 [TBL] [Abstract][Full Text] [Related]
17. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Bujko K; Nowacki MP; Nasierowska-Guttmejer A; Michalski W; Bebenek M; Kryj M Br J Surg; 2006 Oct; 93(10):1215-23. PubMed ID: 16983741 [TBL] [Abstract][Full Text] [Related]
18. [The importance of the interval between preoperative radiotherapy and the operation in the treatment of rectal carcinoma]. Rödel C Strahlenther Onkol; 2000 Mar; 176(3):153-4. PubMed ID: 10742840 [No Abstract] [Full Text] [Related]
19. Preoperative chemotherapy and radiotherapy for locally advanced rectal cancer. Chao M; Gibbs P; Tjandra J; Cullinan M; McLaughlin S; Faragher I; Skinner I; Jones I ANZ J Surg; 2005 May; 75(5):286-91. PubMed ID: 15932438 [TBL] [Abstract][Full Text] [Related]